Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,847 public trials 2,102 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Not yet recruiting

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

NCT06539091

Conditions: Adnexal Diseases, Bone Mineral Density, Carcinoma, +21 more
Locations: Not specified

View Trial Details

Not yet recruiting

Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma

NCT06539377

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab

NCT06535737

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Phase II Study of MRG003 Injection Combined With Pucotenlimab Injection ± Cisplatin Injection in the Neoadjuvant Treatment Locally Advanced EGFR-positive Head and Neck Squamous Cell Carcinoma

NCT06530914

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma

NCT06530823

Conditions: Adenocarcinoma, Biliary Tract Carcinoma, Carcinoma, +4 more
Locations: Not specified

View Trial Details

Not yet recruiting

Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma

NCT06530784

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

NCT06523049

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Not yet recruiting

Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations

NCT06519110

Conditions: Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +30 more
Locations: Not specified

View Trial Details

Not yet recruiting

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

NCT06310369

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma

NCT06512467

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details